Giulia Zorzi

Dr. Giulia Zorzi

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2016 in Immune Network
Verified
Journal Article
Open access
PDF file
VSVincenzo Sorrenti
Vincenzo Sorrenti
BMBruno Marenda
Bruno Marenda
Stefano FortinguerraStefano Fortinguerra
Stefano Fortinguerra
CCClaudia Cecchetto
Claudia Cecchetto
RQRoberta Quartesan
Roberta Quartesan
ABAlessandro Buriani
Alessandro Buriani
Sorrenti V, et al. Immune Netw. 2016 Dec;16(6):344-357. https://doi.org/10.4110/in.2016.16.6.344

8 July 2023 in Diagnostics
Verified
Journal Article
Open access
PDF file
Halil YildizHalil Yildiz
Halil Yildiz
CLCharlotte Lepere
Charlotte Lepere
GZGiulia Zorzi
Giulia Zorzi
OGOlivier Gheysens
Olivier Gheysens
FRFabien Roodhans
Fabien Roodhans
LPLucie Pothen
Lucie Pothen
[18F]FDG-PET/CT is a useful tool for diagnosis and cancer detection in idiopathic inflammatory myopathies (IIMs), especially polymyositis (PM) and dermatomyositis (DM). Data deriving from Europe are lacking. We describe [18F]FDG-PET/CT results in a Belgian cohort with IIMs, focusing on patients with PM and DM. All of the cases of IIMs admitted between December 2010 and January 2023 to the Cliniques Universitaires Saint-Luc (Belgium) were retrospectively reviewed. In total, 44 patients were identified with suspected IIMs; among them, 29 were retained for final analysis. The mean age of the retained patients was 48.7 years; 19 patients were female (65.5%). Twenty-two patients had DM and seven had PM. The mean serum creatinine kinase (CK) and the mean CRP levels were 3125 UI/L and 30.3 mg/L, respectively. [18F]FDG-PET/CT imaging was performed for 27 patients, detecting interstitial lung diseases (ILDs) in 7 patients (25.9%), cancer in 3 patients (11.1%), and abnormal muscle FDG uptake compatible with myositis in 13 patients (48.1%). All of the patients who were detected to have ILDs via PET/CT imaging were confirmed using a low-dose lung CT scan. Among the patients who were detected to have abnormal muscle FDG uptake via PET/CT scans (13/28), the EMG was positive in 12 patients (p = 0.004), while the MRI was positive in 8 patients (p = 0.02). We further observed that there was a significantly higher level of CK in the group with abnormal muscle FDG uptake (p = 0.008). Our study showed that PET/CT is useful for detecting cancer and ILDs. We showed that the detection of abnormal muscle uptake via PET/CT was in accordance with EMG and MRI results, as well as with the mean CK value, and that the presence of dyspnea was significantly associated with the presence of ILDs detected via PET/CT imaging (p = 0.002).

1 June 2018 in Clinical and Experimental Gastroenterology
Verified
Journal Article
Open access
PDF file
Gregorio PeronGregorio Peron
Gregorio Peron
Stefano Dall'acquaStefano Dall'acqua
Stefano Dall'acqua
Vincenzo SorrentiVincenzo Sorrenti
Vincenzo Sorrenti
MCMaria Carrara
Maria Carrara
Stefano FortinguerraStefano Fortinguerra
Stefano Fortinguerra
ABAlessandro Buriani
Alessandro Buriani
Background: Lactose malabsorption is normally evaluated by measuring exhaled H2 produced by intestinal flora, from unabsorbed lactose. However, differing microbiome composition can lead to the production of CH4 instead of H2; hence, some authors challenge the H2 method sensitivity and favor the evaluation of both intestinal gases. Aim: To compare different approaches to usage of a lactose breath test for lactose malabsorption diagnosis, after medical evaluation of gastrointestinal symptoms. Methods: In a retrospective observational study, we compared the 2 approaches in a population of 282 subjects in Northern Italy. Following oral lactose administration, exhaled samples were harvested every 30 minutes for 4 hours and prepared for H2 and CH4 analysis. Basal gas levels were subtracted from H2 and CH4 ppm and values at 4 hours and peaks were considered for analysis.
Results:
Applying the standard methodology, which takes separately into consideration H2 and CH4 produced in the intestinal lumen, the results indicated that 11.7% of the patients were diagnosed “positive” for hypolactasia, differently from what was expected. Conversely, taking into consideration the sum of H2 and CH4, the percentage increased to 62.8%, closer to the expected one. No significant differences were found when comparing the 2 groups for age, gender, or symptoms. The sizable difference between the 2 approaches is likely linked to gut microbiome variability, and consequently the different production of the 2 gases, in the population. Conclusion: The threshold normally used for lactose breath test should be reconsidered and changed, merging H2 and CH4 stoichiometric values to increase sensitivity.

1 June 2017
Verified
Journal Article
Closed access
ABAndrea Bartolini
Andrea Bartolini
GZGiulia Zorzi
Giulia Zorzi
VBValeria Besutti
Valeria Besutti

29 July 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
GZGiulia Zorzi
Giulia Zorzi
PPPerrin Ngougni Pokem
Perrin Ngougni Pokem
GDGeraldine Dahlqvist
Geraldine Dahlqvist
BDBénédicte Délire
Bénédicte Délire
NLNicolas Lanthier
Nicolas Lanthier
DGDamien Gruson
Damien Gruson
Autoimmune diseases of the liver and biliary tract require timely and accurate diagnosis. This study evaluates the D-tek panel (D-Tek, Mons, Belgium) of 10 immunodot antigens for its effectiveness in diagnosing autoimmune hepatitis (AIH) and primary biliary cholangitis (PBC). We retrospectively analysed serum samples from 111 patients who had undergone routine testing, including indirect immunofluorescence (IIF) and enzyme-linked immunosorbent assays (ELISA), to confirm or exclude autoimmune liver or biliary tract disease. The panel tested for M2/nPDC, M2/OGDC-E2, M2/BCOADC-E2, M2/PDC-E2, gp210, sp100, LKM1, LC1, SLA, and F-actin antigens. Results showed that all positive IIF+ELISA results were confirmed by the immunodot panel, except for two samples from patients never diagnosed with AIH. The immunodot test identified over 20 additional autoantibodies in samples initially negative by IIF, corroborated by laboratory imaging and medical history. The immunodot technique proved to be a quick, sensitive, and specific method with high overall accuracy. This study suggests that the immunodot technique may be an effective screening and confirmatory method for autoimmune liver diseases, potentially improving diagnostic efficiency and accuracy in clinical practice.

18 December 2015 in Microbiologia Medica
Verified
Journal Article
Open access
PDF file
ABAndrea Bartolini
Andrea Bartolini
GZGiulia Zorzi
Giulia Zorzi
ECElena Castellani
Elena Castellani
VBValeria Besutti
Valeria Besutti
The aim of this study is to identify and monitor the presence of Aeromonas spp. strains in stool cultures. We analyzed 5564 stool cultures from September 2012 to August 2013. Sixty-three patients were positive for Aeromonas spp. The most frequent symptoms were: diarrhea (46.0%) and abdominal pain (12.7%). Pediatric subjects were 28. Samples’ microscopic examination showed leukocytes in 38.1% of cases. It is still controversial whether Aeromonas are responsible for human gastroenteritis, but their presence in faecies of symptomatic patients supports their etiologic role. We propose search for toxins by polymerase chain reaction to identify strains that require an antibiotic therapy.